Jason A Zell
Overview
Explore the profile of Jason A Zell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
90
Citations
1949
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
31.
Subramaniam S, Zell J, Kunz P
J Natl Compr Canc Netw
. 2013 Jan;
11(1):5-9.
PMID: 23307976
Everolimus is an mTOR inhibitor commonly used to treat metastatic pancreatic neuroendocrine tumors (pNETs) and renal cell carcinoma, and for posttransplant immunosuppression. This report presents a case of a 36-year-old...
32.
Seery T, Ziogas A, Lin B, Pan C, Stamos M, Zell J
J Gastrointest Surg
. 2012 Dec;
17(2):374-81.
PMID: 23242847
Introduction: Persistent lymph node-positive disease after preoperative radiotherapy for rectal cancer is associated with adverse outcomes. We quantified mortality risks of persistent pathologic lymph nodes in lymph node-positive rectal cancer...
33.
Zell J, Lin B, Ziogas A, Anton-Culver H
J Carcinog
. 2012 Dec;
11:17.
PMID: 23233821
Background: Dietary arginine and meat consumption are implicated in colorectal cancer (CRC) progression via polyamine-dependent processes. Polymorphism in the polyamine-regulatory gene, ornithine decarboxylase 1 (Odc1, rs2302615) is prognostic for CRC-specific...
34.
Rial N, Zell J, Cohen A, Gerner E
Expert Rev Gastroenterol Hepatol
. 2012 Aug;
6(4):507-17.
PMID: 22928902
To reduce the morbidity and mortality from colorectal cancer (CRC), current clinical practice focuses on screening for early detection and polypectomy as a form of secondary prevention, complemented with surgical...
35.
Zell J, Lin B, Madson N, McLaren C, Gerner E, Meyskens F
Cancer Causes Control
. 2012 Aug;
23(10):1739-44.
PMID: 22907422
Background: Chemoprevention with the polyamine-inhibitory regimen difluoromethylornithine (DFMO) + sulindac markedly reduces risk of recurrent adenoma in colorectal adenoma patients. Obesity is associated with risk of colorectal adenoma and colorectal...
36.
Masoomi H, Ziogas A, Lin B, Barleben A, Mills S, Stamos M, et al.
Dis Colon Rectum
. 2012 Apr;
55(5):509-14.
PMID: 22513428
Background: Information about adenosquamous carcinoma of the colon and rectum is scarce because of its extremely low incidence. Objective: The aim of this study was to examine the prognostic significance...
37.
Analysis of prognostic factors for patients with chordoma with use of the California Cancer Registry
Lee J, Bhatia N, Hoang B, Ziogas A, Zell J
J Bone Joint Surg Am
. 2012 Feb;
94(4):356-63.
PMID: 22336975
Background: Chordoma is the most common primary malignant tumor of the spine. It is extremely rare and has been studied primarily in single-institution case series. Using data from a large,...
38.
39.
Raj K, Taylor T, Wray C, Stamos M, Zell J
J Carcinog
. 2011 Apr;
10:6.
PMID: 21483654
Background: Patients with history of colorectal cancer (CRC) are at increased risk for developing a second primary colorectal cancer (SPCRC) as compared to the general population. However, the degree of...
40.
Pan C, Ziogas A, Buchberg B, Raj K, Mills S, Stamos M, et al.
Dis Colon Rectum
. 2011 Apr;
54(5):526-34.
PMID: 21471752
Background: Lymph node retrieval is an independent prognostic factor for survival in rectal cancer. Preoperative radiotherapy has been shown to impact the number of lymph nodes retrieved. Objective: This study...